US EditionA single shot of HPV vaccine may be enough to fight cervical cancer, study finds
A study of more than 20,000 girls found one HPV vaccine dose provides 97% protection against cervical cancer infections for at least five years, supporting simpler immunization.
- On Wednesday, researchers from the U.S. National Cancer Institute and Costa Rica's Agency for Biomedical Research reported a single HPV vaccination appears as effective as two doses at preventing the virus causing cervical cancer.
- Led by the U.S. National Cancer Institute, over 20,000 girls aged 12 to 16 participated in a trial comparing two HPV vaccines, with a delayed second dose and five-year follow-up, against an unvaccinated group.
- The findings, published in the New England Journal of Medicine, show a single HPV shot provides about 97% protection, confirming strong protection for five years, according to the U.S. National Cancer Institute and Costa Rica's Agency for Biomedical Research.
34 Articles
34 Articles
Although most HPV infections go away on their own, some persist and cause cancers that appear years later
Associated Press News
A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
A new study suggests a single HPV vaccination appears just as effective as two doses at preventing the viral infection that causes cervical cancer.
While Robert F. Kennedy Jr. has positioned himself against the Gardasil vaccine, two major studies show that papillomavirus vaccines drastically reduce the risk of cervical cancer.
The HPV vaccine is safe and cuts cervical cancer risk by 80%, 2 large reviews find
The HPV vaccine is very safe and highly effective at preventing cervical cancer, according to two large reviews that support routinely vaccinating adolescents against human papillomavirus
The HPV vaccine is safe and cuts cervical cancer risk by 80%, large reviews find
The HPV vaccine is very safe and highly effective at preventing cervical cancer, according to two large reviews that support routinely vaccinating adolescents against human papillomavirus. HPV is the most common sexually transmitted infection and can cause genital warts. Merck’s Gardasil vaccine, the first version of which was approved in 2006, protects against nine cancer-causing HPV strains. Nearly 60 randomized controlled clinical trials invo…
Coverage Details
Bias Distribution
- 58% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
